Current developments in varicella-zoster virus disease prevention. A report on the varicella-zoster virus workshop convened by the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases on 16-17 November 2006

Authors

  • Anita E Heywood National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children's Hospital at Westmead, University of Sydney
  • Kristine K Macartney National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children's Hospital at Westmead, University of Sydney
  • C Raina MacIntyre National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children's Hospital at Westmead, University of Sydney
  • Peter B McIntyre National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children's Hospital at Westmead, University of Sydney

DOI:

https://doi.org/10.33321/cdi.2007.31.33

Keywords:

varicella zoster virus, vaccine preventable disease

Abstract

A report on the varicella-zoster virus workshop convened by the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases on 16-17 November 2006

Downloads

Download data is not yet available.

References

Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J lnfect Dis 1995;172:706–712.

Heininger U, Seward JF. Varicella. Lancet 2006;368:1365–1376.

Gidding HF, MacIntyre CR, Burgess MA, Gilbert GL. The seroepidemiology and transmission dynamics of varicella in Australia. Epidemiol Infect 2003;131:1085–1089.

Forrest J, Mego S, Burgess M. Congenital and neonatal varicella in Australia. J Paediatr Child Health 2000;36:108–113.

Australian Paediatric Surveillance Unit. Factsheet. Burgess M, Chant K, Forrest J. Congenital and neonatal varicella. Completed study factsheet. 2006. Available from: http://www.apsu.org.au/download.cfm?DownloadFile=69C3ACFF-E352-0E4B-956EC61F8788803A Accessed July 2006.

Macartney KK, Beutels P, McIntyre P, Burgess MA. Varicella vaccination in Australia. J Paediatr Child Health 2005;41:544–552.

Australian Institute of Health and Welfare. Interactive national hospital morbidity data. Principal diagnosis data cubes. National Hospital Morbidity Database. 2006. Available from: http://www.aihw.gov.au/cognos/cgi-bin/ppdscgi.exe?DC=Q&E=/AHS/principaldiagnosis0304

National Health and Medical Research Council. The Australian Immunisation Handbook, 9th edition. Canberra: 2007. In press.

Gilbert GL, Gidding HF, Backhouse J, McIntyre PB. Varicella seroprevalence and vaccine uptake in preschool children. [Letter]. Med J Aust 2005;182:42.

Marshall H, Ryan P, Roberton D. Uptake of varicella vaccine-a cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation. Vaccine 2005;23:5389–5397.

Heywood AE, Macartney KK, Hull B, Wang H, McIntyre P. Age-specific trends in varicella hospitalisations in Australia prior to a universally funded program. [Poster #24]. Communicable Diseases Control Conference. 14–1 5 March 2007; Canberra, Australia.

Gidding HF, Brisson M, MacIntyre CR, Burgess MA. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia. Aust N Z J Public Health 2005;29:544–551.

Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995–2000. JAMA 2002;287:606–611.

Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA 2005;294:797–802.

Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 2005;352:450–458.

Gershon AA. Immune responses to 1 and 2 doses of varicella vaccine. Advisory Committee on Immunization Practices. Record of Proceedings, 29–30 June 2006. Atlanta Georgia. 2006. Available from: http://www.cdc.gov/vaccines/recs/acip/downloads/min-jun06.pdf Accessed July 2006.

Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr lnfect Dis J 2004;23:132–137.

Centers for Disease Control and Prevention. Prevention of Varicella. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56 RR-4:1–38.

LaRussa P, Steinberg S, Meurice F, Gershon A. Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts. J lnfect Dis 1997;176:1072–1075.

Hardy I, Gershon AA, Steinberg SP, LaRussa P. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.[see comment]. N Eng l J Med 1991;325:1545–1550.

Kuter BJ, Hoffman Brown ML, Hartzel J. Safety and immunogenicity of a combination MMRV vaccine (ProQuad®). Human Vaccines 2006;2:205–214.

Schmader K. Herpes zoster in older adults. Clin lnfect Dis 2001;32:1481–1486.

MacIntyre CR, Chu CP, Burgess MA. Use of hospitalization and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia. Epidemiol lnfect 2003;131:675–682.

Conway L, Lenkic C, MacIntyre CR. Herpes zoster and associated health care use in general practice in Australia. Successes in Immunisation. 10th National Immunisation/2nd PHAA Asia Pacific Vaccine Preventable Diseases Conference; July 2006; Sydney.

Taha Y, Scott FT, Parker SP, Syndercombe Court D, Quinlivan ML, Breuer J, et al. Reactivation of 2 genetically distinct varicella-zoster viruses in the same individual. Clin lnfect Dis 2006;43:1301–1303.

Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2271–2284.

Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proceedings of the Royal Society of Medicine 1965;58:9–20.

Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch intern Med 1995;155:1605–1609.

Gershon AA, Mervish N, LaRussa P, Steinberg S, Lo SH, Hodes D, et al. Varicella-zoster virus infection in children with underlying human immunodeficiency virus infection. J lnfect Dis 1997;176:1496–1500.

Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992–2002. J lnfect Dis 2005:191:2002–2007.

Australian Paediatric Surveillance Unit. Current studies. 2006. Available from: http://www.apsu.org.au/download.cfm?DownloadFile=F189AF8B-EFA7-C0F5-8E5DABB0794BBDB5 Accessed July 2006.

Brotherton J, McIntyre P, Puech M, Wang H, Gidding H, Hull B, et al. Vaccine preventable diseases and vaccination coverage in Australia 2001 to 2002. Commun Dis Intell 2004;28 Suppl 2:Sl–S116.

Givney R. Varicella surveillance: simpler than you think? [published erratum in Commun Dis lntell 2003;27:284]. Commun Dis lntell 2003;27:100–101.

Downloads

Published

01/09/07

How to Cite

Heywood, Anita E, Kristine K Macartney, C Raina MacIntyre, and Peter B McIntyre. 2007. “Current Developments in Varicella-Zoster Virus Disease Prevention. A Report on the Varicella-Zoster Virus Workshop Convened by the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases on 16-17 November 2006”. Communicable Diseases Intelligence 31 (September):303-10. https://doi.org/10.33321/cdi.2007.31.33.

Most read articles by the same author(s)

<< < 1 2 3 4 5 6 > >>